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Abstract 
 
Title: An assessment of the effectiveness of Andolex-C ® mouth rinse on oral palliation 
in HIV-infected patients. 
Background: The majority of HIV-infected patients present with oral lesions associated 
with the disease.  HIV-infected patients experience profound disorders like oral infections 
and ulcerations, discomfort and greater levels of social impact than non-HIV patients as a 
result of oral lesions. Studies have indicated that mouth pain is a significant symptom 
reported by HIV-infected patients. In order to relieve pain and discomfort and improve 
quality of life, management of HIV-infected patients should include relief of mouth pain, 
discomfort as well as the social and psychological distress caused by the oral lesions.  
Objectives: To determine the prevalence of oral lesions associated with HIV among a 
cohort of HIV-infected patients. To assess the effectiveness of Andolex-C® mouth rinse 
on oral palliation in HIV-infected patients.  
Methods:  The intervention of Andolex C® mouth rinse plus a proven preventive oral 
hygiene regimen was compared to an established oral hygiene intervention. Two hundred 
and ninety nine patients were randomly assigned into Groups 1 and 2.  Patients in Group 
1 were given toothbrushes and toothpaste and oral hygiene instruction ‘routine oral 
hygiene package’.  Those in Group 2 received Andolex-C® mouth rinse in addition to the 
‘routine oral hygiene package’ given to the first group. A baseline assessment of mouth 
pain and/or discomfort was done via a clinical examination and an assessment of quality 
of life was done using the Oral Health Impact Profile (OHIP) questionnaire. The 
intervention was carried out over a four week period after which a follow-up assessment 
was done using the same tools. Comparison of baseline versus post-treatment scores was 
performed to determine impact of intervention in both groups. 
Results: The prevalence of combined candidal lesions was 71.6% of which 
Pseudomembranous candidiasis was 43.2%. Erythematous candidiasis and angular 
cheilitis were the next commonly seen, each with an equal prevalence of 14.2 %.  
Group 2 (Andolex-C® mouth rinse) showed a statistically significant improvement in 
quality of life on all subscales related to functioning, pain, psychological and social 
aspects when using the OHIP index. The patients demonstrated substantial reduction of 
  
[64%] of mouth pain and/or discomfort and a 73% reduction of oral lesions compared to 
Group 1 where there was a much smaller [22%] reduction of mouth pain and/or 
discomfort and a 40% reduction of the oral lesions.   
Conclusion: Andolex-C® mouth rinse improved the quality of life of HIV-infected 
patients who presented with mouth pain and/or discomfort and demonstrated that in 
combination with proper oral care and good hygiene habits, this regimen could be 
recommended for oral palliation in HIV positive patients. 
 
 
 
 
